Commentary: "Emergency Use Authorization for Remdesivir: A Pediatric Perspective"

Pediatr Infect Dis J. 2020 Sep;39(9):e234. doi: 10.1097/INF.0000000000002799.
No abstract available

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives*
  • Adenosine Monophosphate / therapeutic use
  • Alanine / analogs & derivatives*
  • Alanine / therapeutic use
  • Antiviral Agents / therapeutic use*
  • COVID-19 Drug Treatment*
  • Clinical Trials as Topic
  • Emergency Treatment
  • Humans
  • Pediatrics
  • United States
  • United States Food and Drug Administration

Substances

  • Antiviral Agents
  • remdesivir
  • Adenosine Monophosphate
  • Alanine